Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non–Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study

Clinical trials frequently include multiple end points that mature at different times. The initial report, typically on the based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disse...

Descripción completa

Detalles Bibliográficos
Autores principales: Garassino, Marina C., Gadgeel, Shirish, Speranza, Giovanna, Felip, Enriqueta, Esteban, Emilio, Dómine, Manuel, Hochmair, Maximilian J., Powell, Steven F., Bischoff, Helge G., Peled, Nir, Grossi, Francesco, Jennens, Ross R., Reck, Martin, Hui, Rina, Garon, Edward B., Kurata, Takayasu, Gray, Jhanelle E., Schwarzenberger, Paul, Jensen, Erin, Pietanza, M. Catherine, Rodríguez-Abreu, Delvys
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2023
Materias:
CLINICAL TRIAL UPDATES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082311/
https://www.ncbi.nlm.nih.gov/pubmed/36809080
http://dx.doi.org/10.1200/JCO.22.01989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082311/
https://www.ncbi.nlm.nih.gov/pubmed/36809080
http://dx.doi.org/10.1200/JCO.22.01989

Ejemplares similares